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Chloride intracellular channel 1 functions in





Background: Little is known about the role of CLIC1 in endothelium. These studies investigate CLIC1 as a
regulator of angiogenesis by in vitro techniques that mimic individual steps in the angiogenic process.
Methods: Using shRNA against clic1, we determined the role of CLIC1 in primary human endothelial cell behavior.
Results: Here, we report that reduced CLIC1 expression caused a reduction in endothelial migration, cell growth,
branching morphogenesis, capillary-like network formation, and capillary-like sprouting. FACS analysis showed that
CLIC1 plays a role in regulating the cell surface expression of various integrins that function in angiogenesis
including b1 and a3 subunits, as well as aVb3 and aVb5.
Conclusions: Together, these results indicate that CLIC1 is required for multiple steps of in vitro angiogenesis and
plays a role in regulating integrin cell surface expression.
Background
The chloride intracellular channel (CLIC) gene family
consists of seven distinct paralogues (p64 and CLIC1-6)
and constitutes a unique class of mammalian channel
proteins that exist as both cytoplasm-soluble proteins
and membrane-bound channels [1]. CLICs are structu-
rally related to the glutathione S-transferase (GST)
superfamily and are defined by an approximately 240
conserved amino acid sequence at the C-terminus [2].
Most of the distinct CLIC proteins are shown to form
channels in artificial bilayers [3-7], but their selectivity
f o rc h l o r i d ea sc h a n n e l si ss t i l lu n d e rc o n t e n t i o n[ 8 , 9 ] .
CLICs and their homologues are highly conserved
among both vertebrates and invertebrates [10,11].
Since their discovery, members of the CLIC family
have been implicated in such diverse biological pro-
cesses as apoptosis [12], differentiation [12,13], cell cycle
regulation [1], and cell migration [9] in a variety of dif-
ferent cell types. In separate studies, CLIC4 is found to
promote endothelial proliferation and morphogenesis
[14] and to function in mouse retinal angiogenesis [15].
The current model for the angiogenic function of
CLIC4 involves CLIC4 channel activity in the acidifica-
tion of vesicles [15], a process that may be linked to
lumen formation or tubulogenesis [16]. The Hobert
group also demonstrates the requirement of C. elegans
CLIC4 orthologue EXC-4 expression in preventing cys-
tic disruption of an expanding C. elegans excretory
canal and defines a role for EXC-4 in maintaining
proper excretory canal lumen size [17]. A chimeric con-
struct expressing human CLIC1 with the putative trans-
membrane domain (PTM) of exc4 is able to rescue the
cystic disruption phenotype of the excretory canal in
exc4 null mutants, suggesting that CLIC4 and CLIC1
may have overlapping functions [10].
To date, six CLIC genes (CLIC 1-6) are identified in
mice and humans, and CLIC1 and CLIC4 are reported
to be strongly expressed in endothelial cells [17-19]. As
CLIC4 is linked to the process of angiogenesis and
lumen formation within endothelial cells [15,20], interest
in the possibility that other CLICs are involved in angio-
genesis has grown. Structural studies indicate that oxi-
dized CLIC1 forms dimers in artificial bilayers and
vesicles with the PTM located near the N-terminus
[4,21]. It is also suggested that CLIC1 activity is depen-
dent on pH [22]. Studies localize CLIC1 to the nuclear
membrane and it is suggested that CLIC1 can regulate
the cell cycle of CHO-K1 cells [1]. CLIC1 is almost ubi-
quitously expressed in human and mouse adult and fetal
* Correspondence: jkk9@columbia.edu
1Department of Obstetrics/Gynecology, Herbert Irving Comprehensive
Cancer Center, Columbia University Medical Center, 1130 St. Nicholas Ave,
926, New York, NY 10032, USA
Full list of author information is available at the end of the article
Tung and Kitajewski Journal of Angiogenesis Research 2010, 2:23
http://www.jangiogenesis.com/content/2/1/23 JOURNAL OF
ANGIOGENESIS RESEARCH
© 2010 Tung and Kitajewski; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.tissue [1] and is shown to be F-actin regulated, suggest-
ing that it could function in solute transport, during any
number of stages in the cell cycle, or during cell migra-
tion [9]. In several columnar epithelia tissue samples,
including but not limited to the renal proximal tubes,
small intestine, colon, and airways, CLIC1 is found to be
expressed in the apical domains suggesting a role in api-
cal membrane recycling [18]. The same study also finds
that CLIC1 subcellular distribution is polarized in an
apical fashion in human colon cancer cells while another
study finds it localized to intracellular vesicles in renal
proximal tubule cells [23]. Since the process of angio-
genesis is known to involve endothelial cytoskeletal
reorganization, apical-basal polarization, and prolifera-
tion [24,25], these studies suggest CLIC1 may function
in endothelial morphogenesis by influencing some or all
of these cellular and subcellular processes.
Most recently, the Breit group generated a CLIC1
knockout mouse and report platelet dysfunction as well
as inhibited clotting in CLIC1 nullizygous mice [26].
There are no other gross phenotypes reported in the
CLIC1 nullizygous mice. Given the previously defined
roles of CLIC4 in angiogenesis, the suggestion of func-
tional redundancies between CLIC4 and CLIC1, and the
implications of CLIC1 involvement in cytoskeletal orga-
nization and apical membrane recycling, we now seek to
define the role of CLIC1 in endothelial cell behavior and
angiogenesis.
Here, we demonstrate the importance of CLIC1
expression in multiple steps of in vitro angiogenesis as
well as elucidating a role for CLIC1 in regulating integ-
rin cell surface expression. We show that with reduced
CLIC1 expression there is reduced endothelial migra-
tion, cell growth, branching morphogenesis, capillary-
like network formation, and capillary-like sprouting.
CLIC1 also plays a role in regulating the cell surface
expression of various integrins important in angiogen-
esis, including aVb3 and aVb5 and subunits b1 and a3.
Methods
Antibodies
Primary polyclonal rabbit anti-human CLIC1 (B121)
antibody was a gift from Mark Berryman at Ohio Uni-
versity College of Osteopathic Medicine (Athens, OH)
[27]. Primary polyclonal rabbit anti-human CLIC4 anti-
body was purchased from Abcam Inc. (Cambridge, MA)
while primary monoclonal mouse anti-a-tubulin anti-
body was purchased from Sigma-Aldrich (St. Louis,
MO). Primary monoclonal mouse anti-human antibodies
for integrin subunit chains a2, b1, and a3w e r ep u r -
chased from BD Biosciences (San Jose, CA) and primary
monoclonal mouse anti-human antibodies for integrins
aVb3a n daVb5 were purchased from Millipore (Biller-
ica, MA). Primary monoclonal mouse anti-human CD31
antibody was purchased from Dako (Carpinteria, CA).
Secondary goat anti-rabbit and goat anti-mouse horse-
radish peroxidase (HRP)-conjugated antibodies were
purchased from Sigma (St. Louis, MO). Secondary goat
anti-mouse allophycocyanin( A P C ) - c o n j u g a t e dA f f i n i -
Pure IgG antibody was obtained from Jackson Immu-
noResearch Laboratories, Inc. (West Grove, PA).
Cell culture
Human umbilical venous endothelial cells (HUVEC)
were isolated from human umbilical veins as described
previously [28]. HUVEC were cultured on dishes coated
with Type I rat tail collagen (VWR, West Chester, PA)
in EGM-2 BulletKit medium (Lonza, Basel, Switzerland)
without hydrocortisone unless otherwise noted. Detroit
551 fibroblasts and 293T cells (ATCC, Manassas, VA)
were cultured in Eagle’s Minimum Essential Medium
(ATCC, Manassas, VA) and Iscove’s Modified Dulbec-
co’s Medium (Invitrogen, Carlsbad, CA), respectively.
Both media were supplemented with 10% fetal bovine
serum and 1× Pen-Strep (Invitrogen, Carlsbad, CA). All
cells were maintained under standard humidified incu-
bator conditions at 37°C and 5% CO2.
CLIC1 gene silencing
Ah u m a nclic1 shRNA-containing construct in lentiviral
vector pLKO.1-puro (Sigma-Aldrich, St. Louis, MO) was
used to provide clic1 knockdown in HUVEC, which was
confirmed by immunoblotting. The clic1-targetting
shRNA possessed the target sequence of 5’-
CCTGTTGCCAAAGTTACACAT-3’. Lentiviral vector
pLKO.1-puro expressing scrambled shRNA that does
not target any known human genes was used as the
control (Sigma-Aldrich, St, Louis, MO). pLKO.1-puro
plasmids were used for lentivirus-mediated stable
expression of clic1 shRNA or scrambled shRNA in
HUVEC. To generate lentiviral particles for stable infec-
tion, 2.5 × 10
6 293T cells were seeded on a 10 cm tissue
culture dish and transfected with lentivirus-packaging
components pVSVG (3 μg), pMDLg/pPRE (5 μg), and
pRSV-Rev (2.5 μg) along with 10 μga p p r o p r i a t e
pLKO.1-puro plasmid. 293T-generated lentivirus-con-
taining supernatants were then collected at 48 and 56 h
post-transfection, filtered through a 0.45 μm syringe fil-
ter, and immediately added to low-passage HUVEC
seeded at 1 × 10
6 cells per 10 cm collagen-coated dish
for stable infection. 48 h after the last infection,
pLKO.1-puro-expressing HUVEC were selected with
puromycin at 3 μg/mL for 72 h and maintained with
puromycin in EGM-2 at 1.5 μg/mL.
Immunoblotting
HUVEC protein lysates were prepared in TENT lysis
buffer (50 mM Tris pH 8.0, 2 mM EDTA, 150 mM
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tor Cocktail Set IV (EMD Chemicals, Inc., Gibbstown,
NJ) prepared according to the manufacturer’sp r o t o c o l .
Lysates were boiled for 5 min after addition of SDS and
b-mercaptoethanol-containing sample buffer. Protein
concentrations were determined using the Bradford pro-
tein assay (Bio-Rad Laboratories, Hercules, CA) accord-
ing to the manufacturer’s protocol, and sample volumes
were adjusted to equivalent concentrations for equal
protein loading into SDS-PAGE. Protein was then elec-
troblotted onto nitrocellulose membrane and blocking
occured in 5% milk dissolved in PBST (1× PBS with
0.2× Tween20). Incubation of primary antibody (1:250
for CLIC1; 1:250 for CLIC4; or 1:5000 for a-tubulin)
was done in 2.5% milk dissolved in PBST, and incuba-
tion of secondary antibody (1:5000 for both HRP-conju-
gated goat anti-rabbit and goat anti-mouse) occurred in
2.5% milk in PBST. Protein bands were visualized using
Enhanced Chemiluminescence (GE Healthcare Bio-
Sciences Corp., Piscataway, NJ) according to the manu-
facturer’s protocol.
Cell viability and cell growth assays
HUVEC were seeded at 3 × 10
4 cells/well of a 24-well
plate and cultured in either serum free medium (SFM)
alone or SFM with 20 ng/mL epidermal growth factor
(EGF) for 48 h for cell viability assays (Invitrogen, Carls-
bad, CA). Cell numbers after 48 h were quantified using
Cell Counting Kit-8 WST-8 (Dojindo Molecular Tech-
nologies, Gaithersburg, MD) according to the manufac-
turer’s protocol. Similarly for cell growth assays,
HUVEC were seeded at 1 × 10
4 cells/well of a 24-well
plate and cultured in SFM with 20 ng/mL EGF and 20
ng/mL recombinant human vascular endothelial growth
factor A (rhVEGF) for 96 h (Invitrogen, Carlsbad, CA).
Again, cell numbers were scored using Cell Counting
Kit-8 WST-8, and a calibration curve was generated fol-
lowing Dojindo’s protocol (Gaithersburg, MD). Assays
were performed in triplicate and replicated at least five
times.
Migration “scratch” analysis and TScratch quantification
As previously described, HUVEC were seeded to conflu-
ence at 1 × 10
6 cells/well of a 6-well plate and cultured
in EGM2 medium [14]. 24 h post-seeding, cell mono-
layers were bisected along the diameter of each well
with a 200 μL pipette tip, creating an open “scratch” or
“wound” that was clear of cells. The dislodged cells were
removed by three washes with 1× PBS, EGM-2 medium
was replaced, and cells were incubated under standard
conditions. Migration into the open area was documen-
ted at 0, 3, 6, 9, and 12 h post-scratching. Quantification
was done using TScratch software and performed
according to the creator’s protocol [29]. Experiments
were done in triplicate and repeated at least five times.
Flow cytometry
1.5 × 10
5 HUVEC were incubated at 4°C on a rotator
for 1 h with primary antibody (1:50 for each of a2, b1,
a3, aVb3, aVb5, CD31, and without primary for nega-
tive controls) in PCN (0.1% NaN3, 0.001 M MgCl2, 0.5%
FBS in 1× PBS). Cells were incubated with secondary
antibody (1:100 for APC-conjugated goat anti-mouse in
PCN) on a rotator for 45 min at 4°C and kept on ice
overnight. The BD FACSCalibur was used to perform
flow cytometry according to the manufacturer’s protocol
and data analysis was performed using CD CellQuest
Pro software (San Jose, CA). Experiments were repeated
at least three times.
Network formation assay and quantification
H U V E Cw e r ec u l t u r e da ts t a n d a r dc o n d i t i o n sa sa
monolayer between two layers of porcine collagen gel
(Wako USA, Richmond, VA) as previously described
for the network formation assay [14,30]. Briefly,
HUVEC were seeded between two layers of porcine
collagen gel at 1 × 10
5 cells/well of a 24-well plate.
Gels were cultured in SFM supplemented with 20 ng/
mL EGF and 20 ng/mL rhVEGF for 96 h. For quantifi-
cation, MTT (Dojindo Molecular Technologies,
Gaithersburg, MD) was applied to gels for 3 h at the
termination of the assay as previously described [14].
Image-Pro Plus software (Media Cybernetics, Bethesda,
MD) was then used to calculate the surface area occu-
pied by MTT-treated HUVEC. Branchpoints were
tabulated at the termination of the assay with one
branchpoint considered to be any intersection of two
or more cords. Experiments were performed in tripli-
cate and repeated at least five times.
Capillary-like sprouting fibrin bead assay and
quantification
The capillary-like sprouting assay was performed as pre-
viously described [31] with two additional modifications
[14]. Briefly, primary HUVEC and Detroit 551 fibro-
blasts were exposed to M199 medium with 10% FBS
and 1× Pen-Strep (Invitrogen, Carlsbad, CA). HUVEC
were attached to dextran-coated Cytodex 3 beads (GE
Healthcare Bio-Sciences Corp., Piscataway, NJ) at 400
HUVEC/bead and embedded at 250 beads/well of a 24-
well plate in a fibrin clot. D551 fibroblasts were then
seeded as a monolayer over the clot at 1.5 × 10
5 cells/
well. Clots were cultured ats t a n d a r dc o n d i t i o n si n
EGM-2 medium and the assay was allowed to run for
11 days. Experiments were performed in triplicate and
replicated at least three times.
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Unless otherwise noted, independent two-tailed Stu-
dent’s t-tests were performed on all quantified data to
determine significant differences. P values less than 0.05
were considered statistically significant, and equal var-
iances were assumed.
Ethics statement
No human or animal subjects were used in this study.
The collection of HUVEC from umbilical cords was
approved by Columbia University IRB-AAAE4646.
Results
Generation of endothelial cell lines with stable CLIC1
knockdown
Human umbilical venous endothelial cell (HUVEC) lines
with stable CLIC1 knockdown expression were used to
determine the function of CLIC1 in various steps of
angiogenesis, modeled with in vitro assays. Endothelial
cell lines were generated using lentiviral-based vectors
carrying clic1-targeting shRNA. Immunoblotting for
CLIC1 confirmed knockdown at the protein level with a
reduced band around 31 kDa (Figure 1a) [27]. Immuno-
blotting for CLIC4 indicated that the clic1 shRNA did
not target CLIC4 and that CLIC4 expression levels were
not affected by CLIC1 knockdown. CLIC1 knockdown
HUVEC phenotypes were compared to control endothe-
lial cells stably expressing the lentivirus-based vector
backbone carrying a scrambled shRNA insert that is not
known to target any human genes (hereafter referred to
as “control”).
The cellular morphology of CLIC1 knockdown
HUVEC was qualitatively assessed and we observed no
major changes in morphology with respect to control
Figure 1 Establishing human endothelial cell lines with CLIC1 knockdown. A. Immunoblotting with polyclonal rabbit anti-CLIC1 antibody
confirmed reduced CLIC1 protein expression in CLIC1 knockdown (C1 kd) endothelial cell lines. Immunoblotting with rabbit polyclonal anti-
CLIC4 antibody verified that CLIC4 expression was not altered by clic1-targetting shRNA. Alpha-tubulin served as a loading control. B. Established
HUVEC control and CLIC1 knockdown lines exhibited no gross morphological differences when cultured as a subconfluent monolayer on
collagen-coated dishes. Scale bar, 30 μm.
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control cell lines were seeded in equal numbers as a
subconfluent monolayer on collagen-coated plates and
photographed 48 h later. While no gross morphological
changes were present, we noted that CLIC1 knockdown
cells appeared less dense than control cells, indicating
that CLIC1 knockdown may affect endothelial cell
growth.
CLIC1 knockdown inhibits endothelial cell growth
To determine if CLIC1 is involved in regulating
endothelial cell viability or growth, we utilized WST-8
colorimetric cell counting assays to score cells under
different conditions. Cell viability assays were performed
on CLIC1 knockdown or control cells by seeding equal
numbers of HUVEC on collagen-coated plates and scor-
ing cells after being cultured for 48 h in serum-free
medium (SFM) alone or SFM supplemented with the
survival signal EGF. Cell counts in medium without sur-
vival factor EGF were then scored relative to cell counts
of the same cell line in medium with EGF to produce a
percentage of cells that remain viable in medium
without EGF. In the absence of EGF, we found that
CLIC1 knockdown cells displayed a modest but signifi-
cant increase in HUVEC viability (p < 0.05), indicating
that CLIC1 knockdown may play a limited role in regu-
lating cell viability (Figure 2a).
To determine the effects of knocking down CLIC1 on
endothelial cell growth, CLIC1 knockdown or control
HUVEC were seeded in equal numbers on collagen
coated plates and cultured in SFM supplemented with
survival signal EGF and VEGF to induce endothelial cell
growth. Cells were allowed to grow for 96 h, and cells
were then scored using WST-8 colorimetric detection.
In contrast to the effect on cell viability, we found that
reduction of CLIC1 expression led to a pronounced and
significant reduction of HUVEC cell growth (p < 0.001),
indicating that CLIC1 is involved in regulating endothe-
lial cell growth (Figure 2b).
CLIC1 knockdown inhibits endothelial migration
Given the previously described associations of CLIC1
with cytoskeletal elements [9], we utilized a directed
cell migration scratch assay to determine if CLIC1
Figure 2 CLIC1 knockdown has mild effects on viability and significantly inhibits endothelial cell growth. A. CLIC1 knockdown mildly but
significantly increased viability in endothelial cells 48 h post-seeding. Quantification of viability is shown as mean percentages relative to the
respective starting number of cells with standard deviation. (*p < 0.05). B. Reduced CLIC1 expression drastically and significantly inhibited
endothelial cell growth. The line at 10000 cells on the y-axis indicates the number of cells at the start of the assay. Quantification of cell growth
is shown as the mean number of cells for each group with standard deviation. (**p < 0.001).
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This assay involved creating an “open wound” across a
confluent monolayer of HUVEC growing on collagen
and documenting cell migration into the wounded area
at various time points over a 12 h period. We found
that CLIC1 knockdown resulted in reduced endothelial
migration into the wounded area when assessed on a
qualitative level (Figure 3a). Given that the CLIC1
knockdown migratory defects are qualitatively notice-
able as early as 3 h post-wounding and the migration
assay terminated only 12 h post-wounding, it was unli-
kely that any CLIC1 knockdown effects on endothelial
survival or proliferation affected migration assay
outcomes.
Figure 3 Reduced CLIC1 expression inhibits endothelial migration. A. CLIC1 knockdown endothelial lines exhibited inhibited directed
migration in a scratch assay, noticeable as early as 3 h post-wounding. Photographs shown here have been analyzed using the TScratch
software for quantifying open surface area. Lighter shaded areas indicate area occupied by endothelial cells while darker shaded areas indicate
surface area not occupied by endothelial cells. Scale bar, 50 μm. B. Quantification using the TScratch software showed that there was
significantly more open surface area in the CLIC1 knockdown group at and after 6 h post-wounding. Mean open surface area for each group is
shown with standard deviation. (*p < 0.02; **p < 0.001).
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expression was inhibiting directed endothelial cell
migration, TScratch software was used for quantifying
open surface area [29]. Quantification of data collected
from six separate experiments confirmed that CLIC1
knockdown cells occupy significantly less surface area at
6 (p < 0.02), 9 (p < 0.001), and 12 h (p < 0.001) post-
wounding (Figure 3b), indicating that CLIC1 knockdown
significantly reduced directed endothelial cell migration
as early as 6 h post-wounding. Thus, inhibiting CLIC1
expression reduces directed endothelial cell migration.
CLIC1 influences expression of select integrins in
endothelial cells
To explore the regulatory role of CLIC1 in endothelial
migration further, we analyzed the effects of CLIC1
knockdown on various integrins by flow cytometry. For
this assessment, CLIC1 knockdown and control HUVEC
were cultured as subconfluent monolayers on either
Type I collagen-coated or fibronectin-coated plates and
incubated with primary antibodies for various integrins.
A secondary APC-conjugated antibody was then used to
enable flow cytometry. Integrins examined include a2,
b1, a3, aVb3, and aVb5. Endothelial marker CD31
served as a positive control while the absence of primary
antibody served as a negative control. In addition to
being important for cell attachment and migration on
specific extracellular matrices, each of the integrins
examined have been reported to affect the angiogenic
process [32-36].
Expression analysis revealed the same general expres-
sion patterns for HUVEC gro w ne i t h e ro nc o l l a g e n -
coated plates (Figure 4, left panels) or HUVEC grown
on fibronectin-coated plates (Figure 4, right panels). The
expression assays were done three times and results
from a typical flow experiment are depicted in Figure 4.
A slight downward shift in CD31 was found to be typi-
cal of CLIC knockdown cells. Analysis from both plate
types indicated that HUVEC with CLIC1 knockdown
had increased cell surface expression of integrin subu-
nits b1a n da3w h i l ea2 remained mostly unaffected
(Figure 4). Integrin aVb3 surface expression was also
increased in CLIC1 knockdown endothelial cells while
aVb5e x p r e s s i o nw a sd e c r e a s e d on both extracellular
matrix plate types. These results suggest that CLIC1
may be moderating endothelial migration through regu-
lation of integrin expression at the cell surface.
CLIC1 plays a role in capillary-like network formation
We next determined the effect of CLIC1 knockdown on
endothelial cell morphogenesis by assessing the ability
of HUVEC to organize into capillary-like networks. To
do this, CLIC1 knockdown or control HUVEC were
seeded in equal numbers between two layers of porcine
collagen gel and cultured in SFM supplemented with
VEGF and EGF for 96 h. Qualitative assessment of the
results indicated a reduction in cord, network, and
branch formations in CLIC1 knockdown relative to con-
trol (Figure 5a). Network formation from cells with
reduced CLIC1 expression was noticeably less dense
when compared to control cells as indicated by more
prevalent open surface area (indicated by blue arrow-
heads, compared to control black arrowheads). In addi-
tion to these defects, we found dramatic cell
aggregations at branchpoints when CLIC1 was knocked
down, where one branchpoint was considered any inter-
section of two or more cords (indicated by red arrows,
compared to control black arrows). This phenotype
could have been due to the migratory defects established
earlier. As indicated in a previous study assessing CLIC4
function, these cell aggregations are not due to prolif-
erative defects [14].
Quantification of these results revealed that there is a
significant reduction in surface area coverage by CLIC1
knockdown cells (p < 0.01) (Figure 5b). This was accom-
panied by a significant decrease in branchpoints formed
by CLIC1 knockdown (p < 0.001) (Figure 5c). The
decrease in surface area coverage in CLIC1 knockdown
could have been due to the previously established prolif-
erative defect in CLIC1 knockdown HUVEC, however
the reduction in branchpoint formation was novel, indi-
cating that reduced CLIC1 expression inhibits endothe-
lial network formation and branching.
Reduced CLIC1 expression affects capillary-like sprouting
and branching
Next, we assessed the effect of CLIC1 knockdown on
capillary-like tube formation in a fibrin bead assay,
which allowed for assessment of endothelial growth,
sprouting, branching, and lumen formation. For this
assay, CLIC1 knockdown and control HUVEC were
attached to dextran-coated beads and embedded in a
fibrin clot with fibroblasts seeded as a monolayer on top
of the clot. The clot was cultured in EGM-2 medium,
and HUVEC morphogenesis was monitored and photo-
graphically documented for 11 days. As previously
reported, resultant sprouts from this assay are multicel-
lular, lumen-containing processes [31,37]. In this assay,
sprouting is noticeable as early as three days post
embedding. Sprouts are reported to extend, anastomose,
and undergo tubulogenesis from day 4 until the termi-
nation of the assay at day 11.
Our results indicated that knocking down CLIC1
expression resulted in stunted capillary sprouting and
branching with little apparent effect on lumen formation
(Figure 6a-b). Upon quantification of results from day
11, we found that the number of sprouts per bead and
the average number of branches per sprout were
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(p < 0.001) while the number of lumen-containing
sprouts was not different (Figure 6c-e). The branching
defect found in this assay was consistent with the
branching defect found in the previous capillary-like
network formation assay. Together, these data demon-
strate that CLIC1 expression is required for capillary
sprouting and branching morphogenesis, when assessed
in vitro.
Discussion
We have previously shown that CLIC4 knockdown
results in lower endothelial cell growth and inhibited
network formation, similar to the CLIC1 knockdown
results shown here [14]. However, in contrast to the fail-
ure of CLIC4 knockdown cells to form networks, CLIC1
knockdown cells formed rudimentary networks but had
a branching morphogenesis defect whereby cell aggre-
gates formed at branchpoints. We suspect these cell
Figure 4 CLIC1 expression plays a role in the expression of various integrins. Histograms from a typical flow experiment indicate that
HUVEC with CLIC1 knockdown (green) had increased b1, a3, and aVb3 expression and decreased aVb5 expression while a2 expression
remained generally unchanged. Trends persisted despite being cultured on collagen or fibronectin extracellular matrix components. A downward
shift in positive control endothelial marker CD31 was typical with CLIC1 knockdown cells.
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and a failure of knockdown cells to undergo appropriate
branching morphogenesis. This would be consistent
with the observation that CLIC1 knockdown reduced
endothelial cell migration, whereas CLIC4 knockdown
has no effect on migration. Another difference our com-
parison highlights is the lack of a lumen formation
defect in CLIC1 knockdown endothelial cells in contrast
to the lumen formation defect previously found with
C L I C 4k n o c k d o w n[ 1 4 ] .T oe x p l o r et h ep o s s i b i l i t yo f
functional redundancy between CLIC1 and CLIC4, we
made several attempts to generate HUVEC lines with
both CLIC1 and CLIC4 knockdown. In contrast to
HUVEC introduced with two different control vectors,
all attempts to create double knockdown cell lines did
not result in viable HUVEC. We found this observation
consistent with the hypothesis that CLIC1 and CLIC4
may possess functional redundancies.
CLIC1 is found to be significantly up-regulated in
highly metastatic gallbladder carcinoma cell lines [38].
More generally, chloride transport is reported to be
integral in generating electrical signals that guide cell
Figure 5 Knocked down CLIC1 expression inhibits capillary-like network formation and branching morphogenesis.A .M i c r o s c o p yo f
control or CLIC1 knockdown lines in a collagen network formation assay indicated decreased network formation and defective branching
morphogenesis in cells with CLIC1 knockdown. In addition to having less dense network patterning (exemplified by blue arrowheads), cell
aggregations were found where normal branchpoints should have been (exemplified by red arrows). Black arrowheads indicate regularly spaced
network patterning, and black arrows indicate normal branchpoints. Scale bar, 50 μm. B. Quantification of surface area occupied by endothelial
cells showed a significant decrease in surface area occupation by cells with CLIC1 knockdown. Mean surface area occupied by endothelial cells
for each cell line is shown with standard deviation. (*p < 0.01). C. Quantification of branchpoint numbers revealed a significant decrease in the
number of branchpoint formations in cells with CLIC1 knockdown. One branchpoint was considered any focal intersection of two or more cords.
The mean number of branchpoints for each cell line is shown with standard deviation. (**p < 0.001).
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showed that endothelial cells with CLIC1 knockdown had altered sprouting morphology. CLIC1 knockdown sprouts tended to be shorter, less
branched, and less robust. Black arrows indicate long, robust, lumen-containing sprouts while red arrows indicate stunted tube structures. Scale
bar, 10 μm. B. Microscopy on day 11 of the fibrin bead assay showed that endothelial cells with reduced CLIC1 expression formed tube-like
structures; however these structures were stunted and possessed a branching defect when compared to structures formed by control cells. Black
arrows indicate anastomosis or long tube-like structures. Red arrows indicate lack of branching or stunted tube-like structures. Scale bar, 30 μm.
C. The average number of sprouts formed per bead was tabulated and quantified, shown here with standard deviation. Reduced CLIC1
expression was found to be accompanied by a significant reduction in the average number of sprouts per bead. D. Quantification of the
average number of branches per sprout indicated that CLIC1 knockdown endothelial cells formed significantly fewer branches per sprout. The
average number of branches per sprout is shown with standard deviation. E. Quantification of the number of lumen-containing sprouts revealed
no significant difference between control cells and cells with CLIC1 knockdown. The average percentage of lumen-containing sprouts relative to
total number of sprouts per cell line is shown with standard deviation. (**p < 0.001).
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Page 10 of 13migration to wounds in corneal epithelium [39], and
chloride channels are implicated directly in enabling
glioma migration as well as regulating breast cancer
invasiveness [40,41]. One may thus hypothesize that
CLIC1 is required for endothelial cell motility based
upon its potential function as an ion channel.
Extensive work has been done to validate CLIC1 as an
anion channel that can auto-insert into artificial bilayers
and produce conductance [5,22], however the channel
selectivity is found to be poor with conductance being
based on anion concentration [1,4,21,22,42]. As an
anion channel, CLIC1 is redox-regulated and its
sequence contains the putative transmembrane domain
(PTM) purported to be essential for its proper integral
membrane channel characteristics [21,43]. CLIC1 ion
channel activity is also shown to be pH-dependent with
activity lowest around neutral pH [22]. Structural
experiments show that low pH may stimulate the PTM
for insertion [11,44,45]. It will be important to assess
whether these mechanistic features of CLIC1 are impor-
tant for endothelial cell motility.
One of the most interesting structural characteristics
of CLIC1 is the fact that it can exist as both an integral
membrane protein and a soluble cytoplasmic protein. In
contrast to the well-documented anion channel activity
of CLIC1, the roles of CLIC1 independent of its channel
activity are largely unknown. Studies demonstrate that a
variety of CLIC proteins interact with the actin cytoske-
leton either directly [9,46,47] or indirectly mediated by
scaffolding proteins [27,48,49]. With this in mind, we
postulate that CLIC1 may be regulating endothelial cell
migration by regulation of cytoskeletal elements.
Endothelial cell migration and adhesion also depend
on appropriate integrin expression [50]. Studies show
that adhesion to the extracellular matrix through integ-
rin heterodimers is essential for proper endothelial cell
motility, and endothelial migration is at its greatest with
intermediate levels of adhesion [51,52]. Of interest to
our study are integrins aVb3, which can bind with
fibronectin; aVb5, which binds only vitronectin; integrin
subunits a2a n db1, which are known for binding col-
lagens, laminins, and possibly fibronectin [53]; and the
integrin a3 subunit, which binds fibronectin [54]. We
found that reducing CLIC1 expression increased b1, a3,
and aVb3 expression while decreasing aVb5e x p r e s s i o n
(Figure 3), suggesting a role for CLIC1 in mediating
integrin presentation and a means by which CLIC1 may
be affecting endothelial migration. By increasing the sur-
face expression of b1, a3, and aVb3, CLIC1 may be
increasing endothelial cell adhesion to the extracellular
matrix, inhibiting motility by preventing the cell from
breaking its contact with the extracellular matrix. These
shifts in integrin expression also provide a possible
explanation for the cell growth and viability defects [55].
In addition, it is possible that CLIC1 alters integrin
binding affinity for their ligands through inside-out sig-
naling resulting in increased integrin expression but less
efficient ligand binding [56]. To determine a mechanism
by which CLIC1 may be influencing integrin cell surface
expression, we conducted Western blotting for b1a n d
b5 integrin subunits and found that the protein levels of
these integrins were unchanged by CLIC1 knockdown
(data not shown). Based on these preliminary results, we
hypothesize that changes to integrin cell surface expres-
sion are a result of altered cell trafficking as integrins
c y c l et h r o u g ht h ee n d o s o m a lp a t h w a ya n da sac h l o r i d e
channel, CLIC1 contributes to endosomal acidification
[57].
In summary, we demonstrated here that CLIC1 is
involved in several steps of angiogenesis in vitro and
concluded that CLIC1 plays a role in mediating
endothelial cell growth, branching morphogenesis, and
migration, possibly via regulation of integrin expression.
We found that the CLIC1 and CLIC4 knockdown phe-
notypes are similar in that both result in reduced cell
growth, modestly increased cell viability, and inhibited
network formation, but are different in that only CLIC1
knockdown inhibits migration and only CLIC4 knock-
down affects lumen formation. It will be important to
understand the molecular mechanisms by which CLIC1
functions in these diverse endothelial cell behaviors.
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